SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-063558
Filing Date
2011-11-14
Accepted
2011-11-14 09:10:15
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v239347_10q.htm 10-Q 1311874
2 EXHIBIT 31.1 v239347_ex31-1.htm EX-31.1 13581
3 EXHIBIT 32.1 v239347_ex32-1.htm EX-32.1 5977
  Complete submission text file 0001144204-11-063558.txt   4119604

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mhan-20110930.xml EX-101.INS 574848
5 XBRL TAXONOMY EXTENSION SCHEMA mhan-20110930.xsd EX-101.SCH 31534
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mhan-20110930_cal.xml EX-101.CAL 36059
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mhan-20110930_def.xml EX-101.DEF 102075
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mhan-20110930_lab.xml EX-101.LAB 237440
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mhan-20110930_pre.xml EX-101.PRE 129607
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 111198175
SIC: 2834 Pharmaceutical Preparations